58Z-11574-94218
2 vaccinations
7 coded responses
19 check-ins
7 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 51-55
- ZIP prefix
- 945 / CA
- Registered
- 2021-05-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-20
Dose 1 — Pfizer-BioNTech
-
2021-05-21
Registered in v-safe
-
2021-05-21
Survey response — days 1–6 daily, dose 1MedDRA: Anxiety — Feeling: Good · Site: Pain, Swelling · Chills, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Occasional mild anxietyMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-22
- 2021-05-23
- 2021-05-24
-
2021-05-25
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fever · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-05-26
-
2021-05-27
Survey response — day 7, dose 1MedDRA: Paraesthesia, Tachycardia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Tachycardia, tingling in the face, tinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-03
Survey response — day 14, dose 1MedDRA: Dizziness, Tachycardia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Episodes of tachycardia and dizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-10
Survey response — day 21, dose 1MedDRA: Fatigue, Goitre, Tachycardia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Fatigue. Thyroid cyst enlargement. Occasional tachycardia.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-06-17
Dose 2 — Pfizer-BioNTech
-
2021-06-17
Survey response — day 28, dose 1MedDRA: Inflammation, Thyroid pain — Feeling: FairFree text: Continued thyroid pain/inflammation.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-24
- 2021-07-01
- 2021-07-08
- 2021-07-15
-
2021-07-22
Survey response — day 35, dose 2MedDRA: Chest discomfort, Dyspnoea, Tachycardia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Occasional tachycardia and oxygen saturation in the mid 90s. A little breathlessness. Occasional chest tightness.MedDRA releases: 2024-11 · check-in free text available
- 2021-07-31
- 2021-09-16
-
2021-12-16
Survey response — 6 months, dose 2MedDRA: Abnormal menstrual clots, Anaemia, Blood iron decreased, Dizziness, Dyspnoea, Haemoglobin decreased, Heavy menstrual bleeding, Serum ferritin decreased, Tachycardia — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Heavy menstrual periods with passing major clots, dizziness, tachycardia, breathlessness, super low ferritin, low iron, low hemoglobin, anemiaMedDRA releases: 2024-11 · check-in free text available
-
2021-12-16
Report sent to call center — 6 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-12-18
- 2022-06-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-20 | Pfizer-BioNTech | |
| 2 | 2021-06-17 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 8 — days 1–6 daily, dose 1
Systemic reaction (other): Occasional mild anxiety
Release 8 — day 7, dose 1
Systemic reaction (other): Tachycardia, tingling in the face, tinnitus
Release 8 — day 14, dose 1
Symptoms: Episodes of tachycardia and dizziness
Release 9 — day 21, dose 1
Symptoms: Fatigue. Thyroid cyst enlargement. Occasional tachycardia.
Release 9 — day 28, dose 1
Symptoms: Continued thyroid pain/inflammation.
Release 9 — day 35, dose 2
Symptoms: Occasional tachycardia and oxygen saturation in the mid 90s. A little breathlessness. Occasional chest tightness.
Release 10 — 6 months, dose 2
Symptoms: Heavy menstrual periods with passing major clots, dizziness, tachycardia, breathlessness, super low ferritin, low iron, low hemoglobin, anemia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abnormal menstrual clots | · | · | ✓ |
| SD | Anaemia | · | · | ✓ |
| SD | Blood iron decreased | · | · | ✓ |
| SD | Chest discomfort | · | · | ✓ |
| SD | Dizziness | ✓ | ✓ | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Goitre | ✓ | ✓ | ✓ |
| SD | Haemoglobin decreased | · | · | ✓ |
| SD | Heavy menstrual bleeding | · | · | ✓ |
| SD | Inflammation | ✓ | ✓ | ✓ |
| SD | Serum ferritin decreased | · | · | ✓ |
| SD | Tachycardia | ✓ | ✓ | ✓ |
| SD | Thyroid pain | ✓ | ✓ | ✓ |
| SRO | Anxiety | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Tachycardia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release